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Exploring the molecular basis of 
age-related disease comorbidities 
using a multi-omics graphical 
model
Jonas Zierer1,2, Tess Pallister1, Pei-Chien Tsai1, Jan Krumsiek3,4, Jordana T. Bell1, 
Gordan Lauc1,5, Tim D Spector1, Cristina Menni1 & Gabi Kastenmüller1,2,4
Although association studies have unveiled numerous correlations of biochemical markers with age and 
age-related diseases, we still lack an understanding of their mutual dependencies. To find molecular 
pathways that underlie age-related diseases as well as their comorbidities, we integrated aging 
markers from four different high-throughput omics datasets, namely epigenomics, transcriptomics, 
glycomics and metabolomics, with a comprehensive set of disease phenotypes from 510 participants 
of the TwinsUK cohort. We used graphical random forests to assess conditional dependencies between 
omics markers and phenotypes while eliminating mediated associations. Applying this novel approach 
for multi-omics data integration yields a model consisting of seven modules that represent distinct 
aspects of aging. These modules are connected by hubs that potentially trigger comorbidities of 
age-related diseases. As an example, we identified urate as one of these key players mediating the 
comorbidity of renal disease with body composition and obesity. Body composition variables are in 
turn associated with inflammatory IgG markers, mediated by the expression of the hormone oxytocin. 
Thus, oxytocin potentially contributes to the development of chronic low-grade inflammation, which 
often accompanies obesity. Our multi-omics graphical model demonstrates the interconnectivity of 
age-related diseases and highlights molecular markers of the aging process that might drive disease 
comorbidities.
Aging is a multi-factorial process that affects the entire organism, thus causing decreased fitness, disease and 
eventually death. As the population of western countries is aging1, the prevalence of a variety of age-related dis-
eases, such as cardiovascular disease, cancer2 and chronic kidney disease (CKD)3 and many related diseases are 
increasing. Finding mechanisms that cause diseases with progressing age as well as better understanding disease 
comorbidity patterns is thus essential to counteract an explosion of health care costs. Epidemiological studies 
have already identified a broad spectrum of molecules associated with aging from various layers of biology acces-
sible through modern omics technologies4. These molecules include epigenetic markers5, RNA abundances6, 
protein abundances7, post-translational protein modifications – such as protein glycosylation8 – and metabo-
lite concentrations9. However, these studies analyzed omics datasets independently, thus neglecting the intrinsic 
interactions of biological entities within and across omics layers. Taking into account this complex interplay is 
necessary to unveil the causal structure of multi-factorial processes such as aging.
Various concepts have been proposed to integrate data from different molecular layers and (omics) technol-
ogies in systems biology and the newly emerging fields of systems genetics10 and systems medicine11. Thereby, 
networks have been shown to be particularly useful to assess complex interactions in a dataset and to illustrate 
multivariate dependencies12. As an example, using network approaches, it was demonstrated that co-occurring 
diseases are linked to mutations in the same gene13, in genes that interact with each other14, or in genes that are 
involved in the same metabolic pathway15, explaining observed patterns of comorbidity16.
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Due to the increasing availability of high-dimensional omics datasets, networks can now be inferred also 
directly from measured data facilitating the unbiased analysis of specific conditions of interest, independently 
of prior knowledge. For instance, gene co-expression networks were used to analyze the influence of anti-cancer 
drugs on gene expression17. Integration of such co-expression networks with other omics layers allowed for pri-
oritization of interesting, potentially causal, targets18. Even though these types of correlation-based networks led 
to a wide range of discoveries, they suffer from vast numbers of spurious correlations that inflate the number of 
edges and obscure the underlying mechanisms. Conditional independence graphs, such as graphical models19, 
were proposed as solution to overcome the problem of mediated associations20 by revealing the relevant direct 
associations between variables. Although the direction of the associations and, thus, causality cannot be deter-
mined by these models in most cases, the resulting network of direct associations between variables can be con-
sidered as the undirected skeleton of their underlying causal structure. While the proposed graphical models are 
well established for multi-variate Gaussian distributed data, the extension to mixed distributions, as commonly 
observed in phenomics data (e.g. gender, disease states), is substantially more complex21.
In this study, we aimed to investigate the molecular basis of age-related diseases and its influence on disease 
comorbidities. To this end, we used an integrated mixed graphical model (MGM) approach to combine aging 
markers from four different high-throughput omics datasets on the same individuals, namely epigenomics, tran-
scriptomics, glycomics and metabolomics, together with extensive phenotypic data. While we cannot infer actual 
causality using MGM, the resulting network of direct associations that are independent of all other variables 
within the model is expected to provide valuable insights into the direct molecular interdependencies between 
various age-related phenotypes. To the best of our knowledge, this is the first study that uses graphical models to 
combine data from multiple molecular omics and phenomics datasets.
Results
We inferred a mixed graphical model using observational data from a cohort of 510 women, aged between 
34 and 84, integrating selected age-associated markers from four different omics datasets (see Materials and 
Methods) with 92 clinically assessed phenotypes (Supplementary Fig. S1). The final model consists of 145 
nodes and 316 undirected edges connecting them (Fig. 1). Thus, it is much sparser (316 edges instead of 
1900) than a regular correlation graph based on significant pairwise correlations of variables from the same 
dataset (Supplementary Fig. S2). Most of the nodes (96) form one large connected component, which 
we refer to as age-mgm in the following. There are two smaller components of 8 and 4 nodes that contain 
variables related to pain and memory function, respectively, two isolated pairs of nodes and 33 unconnected 
nodes. The degree, betweenness and clustering coefficients of all nodes in the network are presented in 
Supplementary Tables S1 and S2.
Figure 1. Multi-Omics MGM of Age. Each node in the graph represents one age-related variable. Omics 
markers were selected according to literature from epigenomics (purple), transcriptomics (brown), glycomics 
(red) and metabolomics (orange) datasets and combined with DXA measurements (green) and other clinical 
phenotypes (yellow). Edges between nodes were inferred using a mixed graphical model approach, and thus 
indicate the conditional dependence between variables; the color represents positive (red) and negative (blue) 
correlation. An unbiased cluster detection algorithm was used to identify densely connected modules within the 
network, indicated by grey borders.
www.nature.com/scientificreports/
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Topological Properties of age-mgm. The large connected component age-mgm contains 96 variables 
including age, along with variables from all four omics datasets, and 286 edges connecting them. It has an average 
node degree of 6.0, an average local clustering coefficient of 46.6% and an average shortest path length of 3.2. 
Also, its small world index, as defined by Humphries and Gurney22, is 6.1 and so the age-mgm can be considered a 
small-world network with high local clustering and short path lengths. Removing age from the network does not 
reduce the small worldness of the network. In comparison, the correlation graph, restricted to the same vertices 
as in the age-mgm, has a just slightly higher clustering coefficient of 57.0% despite the much higher average node 
degree of 31.2, which results in a small world-index of only 1.7.
As expected, age is the most densely connected node with a degree of 27 (Fig. 2a). It has a low clustering coef-
ficient (8.0%) but high betweenness (47.5%) centrality. This indicates that age connects different clusters, while its 
neighbors tend to be unconnected. With an average shortest path length of 2.1 age is also the most central node 
in the age-mgm.
Modularity of the age-mgm. There are more edges between variables originating from the same omics 
dataset than edges connecting them. Particularly transcriptomics and metabolomics variables form dense 
clusters with 37 and 34 edges within them, respectively. In contrast, only 7 edges connect transcriptomics 
and metabolomics variables with variables from other omics sets. Similarly, the body composition variables 
measured by dual-energy X-ray absorptiometry (DXA) are densely connected with 45 edges between them 
(Supplementary Fig. S3).
In order to analyze the graph structure in an unbiased way we used a modularity-based algorithm for cluster detec-
tion. This approach yielded seven modules (Fig. 1). The first cluster (EXPRESSION) contains all but three gene expres-
sion markers. It is connected with neighboring clusters mainly via expression levels of OXT, which has 6 edges outside 
of its cluster (Fig. 2b), and SVEP1, which has the highest betweenness centrality (10.5%) within the cluster. The second 
cluster (LUNG) contains age and several of its direct neighbors from different omics layers. The lung function param-
eters forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) are the most densely connected 
phenotypes in the cluster (degree 8 and 7 respectively). Both are embedded in a tight cluster with local clustering coef-
ficients of 35.7% and 47.6%, respectively (Fig. 2c). Age is also connected to another small cluster of arthritis-related 
variables (ARTHRITIS). The body composition variables fall in two different clusters, one of them containing bone 
density-related variables (BONE) and the other fat and lean mass-related variables (FAT). While the BONE cluster is 
densely connected with the LUNG cluster, all connections between the FAT cluster and the LUNG cluster, containing 
the age variable, are mediated, mainly via gene expression variables from adipose tissue. The next cluster (LIVER) con-
tains the liver markers alanine-aminotransferase (ALAT) and gamma-glutamyl transpeptidase (GGT) along with cho-
lesterol and triglyceride levels and several amino acids. It also contains the gene expression marker of the RBM20 gene 
that mediates the connection of the cluster with age and the LUNG cluster. The last cluster (KIDNEY) contains mainly 
metabolite levels, but also markers for nutrition and a measure of renal function, the estimated glomerular filtration rate 
(eGFR). With 9 edges, C-glycosyltryptophan is central within the metabolite cluster. However, the eGFR (degree 7) 
is the main connection of the metabolomics cluster with age as well as IgG glycosylation markers. The only connec-
tions of the renal cluster with other clusters, apart from the LUNG cluster via age, are edges between urate and the 
FAT and LIVER clusters.
Figure 2. Selected modules from the graphical model. Each panel shows one subgraph from the age-
mgm (Fig. 1). (a) The direct neighborhood of chronological age. (b) The hormone oxytocin (OXT) mediates 
association of fat mass variables with age as well as the IgG glycosylation marker GP14. (c) The direct 
neighborhood of the lung function measures forced expiratory volume in one second (FEV1) and forced vital 
capacity (FVC) contains three omics markers: dehydroepiandrosterone-sulfate (DHEA-S), phosphodiesterase 
4 C (PDE4C) and the glycan peak 14 (GP14).
www.nature.com/scientificreports/
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Robustness of the age-mgm. For estimating the robustness of our model, we inferred additional networks 
based on different cutoffs for edge inclusion and on changed selection of omics variables. Comparing these net-
works with our original model, we found node centrality as well as module assignments to be stable when varying 
the cutoff for edge inclusion (Supplementary Fig. S4). The modules identified in the original age-mgm remained 
stable even when including all available metabolomics variables with known chemical identity, i.e. when basing 
the inference procedure on 196 metabolites in addition to the 23 pre-selected ones (Supplementary Table S4).
To investigate the reproducibility of the inferred age-mgm for a different set of samples we determined two 
separate models from disjoint datasets incorporating the first and second twin of each family, respectively, and 
compared these models to the original network. The two resulting models reproduce 93.5% of all edges, with only 
21 edges being unique to the initial model (Supplementary Fig. S5A, Supplementary Dataset S1). Moreover, in the 
models of the two disjoint datasets these unique edges just missed the edge inclusion cutoff of 80% in most cases, 
which is most likely due to the reduced power in the smaller datasets (Supplementary Fig. S5B).
Discussion
In this study, we inferred a robust graphical multi-omics model of age-related diseases by integrating disease 
phenotypes with molecular markers from four omics layers based on data available for 510 women from the 
TwinsUK cohort. Despite the sparsity of our model, which omits mediated associations, most variables form one 
connected component (age-mgm) consisting of seven modules. Interestingly, each of these modules represents 
a different aspect of aging, such as metabolic aging linked to decline of renal function (KIDNEY cluster). Other 
aspects of aging include the change in body composition, which can be divided in the change of fat and lean tissue 
(FAT cluster), along with the closely related changes of gene expression in adipose tissue (EXPRESSION cluster), 
on the one hand, and the decrease of bone mineral density (BMD) and bone mineral content (BMC) on the other 
hand (BONE cluster) (Fig. 1).
Our model illustrates multivariate dependencies of age-related diseases that potentially explain comorbidity 
patterns. Edges in our model represent conditional dependence between two variables, while the absence of an 
edge implies their conditional independence given all other variables in the model. Specifically, this means that 
previously observed age-associations of the variables, which are not directly linked to age in our model, occur due 
to the mediation by other variables between them. This differentiation between mediated and direct associations 
allows us to draw conclusions on underlying mechanisms even though the causal directions cannot be inferred. 
In the following section we will discuss some key findings from our aging model in detail. Figure 3 summarizes 
additional hypotheses derived from the model, which we will not further discuss for the sake of brevity.
Lung Function is a Central Aging Process. Lung function appears to be a central aging phenotype in 
our age-mgm. Both lung function measures, FEV1 and FVC, are directly connected with age and are, besides age, 
the most densely connected nodes in the LUNG cluster, connected with three different omics markers (Fig. 2c): 
(i) The metabolite dehydroepiandrosterone sulfate (DHEA-S) is one of the most abundant hormones in humans 
and well known to decrease with age23 and was even suggested as an anti-aging drug24. Moreover, DHEA-S has 
been found to prevent and even revert pulmonary hypertension in rats25, suggesting a causal effect of DHEA-S 
on lung function. (ii) The methylation probe cg17861230 lies in the PDE4C gene, an enzyme that catalyzes the 
hydrolysation of cAMP. Expression levels of PDE4C were previously found to be associated with lung function26. 
PDE4 is a potential target for drugs against COPD and a PDE4 inhibitor, Roflumilast, has been approved by the 
EMA for treatment of COPD27. In this example, our graphical model approach indeed unveiled a known causal 
interaction of variables while removing less relevant mediated associations. (iii) Finally, the IgG glycosylation 
marker GP14 is connected to lung function in the age-mgm. GP14 is a glycan structure with terminal galactose, 
which is known to change the inflammatory state of IgG28. While defects of general protein glycosylation29 as 
well as an involvement of IgG30 in COPD have been previously reported, glycosylation of IgG has so far not been 
associated with lung function. Our model suggests a contribution of IgG mediated inflammation and might help 
to unveil mechanisms of lung disease in dedicated experiments. As IgG glycosylation is also related with kidney 
function in our age-mgm as well as in previous studies31, this might provide an explanation for the comorbidity 
of lung disease and renal disease.
Decline of Renal Function Links Age with Metabolic Shift. The blood metabolome was shown to be 
strongly influenced by age in several studies9. In the age-mgm most of the age-associated metabolites (13) form 
one large cluster with only four of them being directly linked to age, while the remaining nine metabolites are 
only indirectly associated with age. For six of these nine metabolites the shortest path to age is through eGFR, a 
measure of renal function. Even though our model is undirected, age is the only non-modifiable variable in our 
model. We thus hypothesize that with increasing age renal function declines leading to the major shift in the aging 
blood metabolome, which possibly causes further diseases.
Urate Mediates Association of Renal Function with Body Composition. Urate mediates the con-
nection of the KIDNEY cluster with FAT and LIVER clusters. Hyperuricemia has been previously reported to 
be associated with obesity, particularly increased visceral fat mass32, and increased triglyceride levels33, which 
appears to be a direct association according to our model. Indeed, there is evidence that urate actually contributes 
to the development of obesity and diabetes, rather than being just a consequence of obesity: Elevated serum levels 
of urate were found to predict, amongst others, obesity34 and diabetes35. By knocking out the uric acid transporter 
SLC2A9 in mice, DeBosch and colleagues found that hyperuricemia causes several phenotypes of the metabolic 
syndrome, including obesity, dyslipidemia and hypertension36. Administering a compensating treatment atten-
uated some but not all of the observed symptoms. Hyperuricemia is also a known comorbidity of renal disease, 
however the causal direction of this association is controversial37. Renal disease and uremia were also shown to 
www.nature.com/scientificreports/
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affect the gut microbiome composition38, which is known to be strongly associated with obesity and other symp-
toms of the metabolic syndrome39. Thus, the microbiome is possibly a hidden mediating factor, not included in 
our model, of the association between hyperuricemia and obesity. Even though its mode of action remains elu-
sive, urate appears to be a key factor for the comorbidity of renal disease and obesity.
Hormone Expression Directly Associates with Body Composition. It is commonly known that BMI 
as well as waist and hip circumferences and body fat mass change with age. Nonetheless, we found neither of them 
directly linked to age in our model. Instead, all associations between age and the fat cluster are mediated. One 
of the paths connecting the FAT cluster with age is channeled via urate and renal function (as discussed above). 
A second path leads via the EXPRESSION cluster and, particularly, the expression of oxytocin (OXT) (Fig. 2b), 
which accordingly mediates 6.0% of all shortest paths in the model. OXT is also directly linked to HDL choles-
terol levels. While adipose tissue was traditionally considered as storage tissue, it receives increasing attention as 
endocrine organ40 that amongst others produces OXT. OXT is a hormone with a broad spectrum of functions, 
ranging from reproductive functions and control of social behavior41 to energy metabolism42. One common 
explanation for the influence of OXT on obesity is its effect on food intake43, but there is also a diet-independent 
effect of OXT on the lipid metabolism in adipose tissue44. Thus, OXT was suggested as drug against obesity and 
type 2 diabetes development and has been successfully tested in a first pilot trial45. Our results indicate that the 
age-related change of body composition can, amongst others, be attributed to alterations of gene expression in 
adipose tissue and particularly to a change in OXT expression, independently of food intake. OXT might also 
drive common comorbidities of obesity by causing dyslipidemia, which in turn increases the risk of – amongst 
others – cardiovascular diseases46.
IgG Glycosylation as New Mechanism of Obesity-Associated Inflammation. Obesity is known 
to be associated with chronic low-grade inflammation and activation of immune function47, which is thought to 
be an important mediator between obesity and common comorbidities, such as type 2 diabetes48. In our model 
the expression of OXT mediates the association of android and visceral fat mass with inflammatory IgG glycosyl-
ation. The influence of oxytocin on IgG might be mediated by IL6, which was found to be less expressed due to 
Figure 3. Additional implications of the age-mgm. The figure summarizes selected conclusions drawn 
from our age-mgm that are not discussed in detail in the main text. Each panel shows a small excerpt from the 
network, restricted to relevant nodes and edges. Coloring is consistent with Fig. 1.
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6Scientific RepoRts | 6:37646 | DOI: 10.1038/srep37646
OXT in vitro49 and thus causes decreased IgG production in B-cells50. Our study confirms an effect of increased fat 
mass on IgG, mediated by OXT, in vivo. Moreover, it provides evidence that OXT also affects IgG glycosylation in 
addition to its expression, thus altering its inflammatory potential. We hypothesize that this is a new mechanism 
of obesity-induced inflammation, which appears to be independent from previously identified pathways that are 
mediated by leptin or adiponectin51. Both of them are co-expressed with OXT in our data (Pearson correlation 
r = 0.2, p = 8.1*10−9 and r = − 0.29, p = 6.1*10−17 respectively), but not associated with any of the IgG glycosyla-
tion markers.
We also found IgG-mediated inflammation being directly linked with renal function (Fig. 3), suggesting 
altered inflammatory potential of IgG as possible mechanism causing comorbidities of renal disease, obesity 
and related phenotypes of the metabolic syndrome. This supports the theory of “inflammaging”, which proposes 
chronic low-grade inflammation as mechanism that drives disease onset during aging52.
Limitations and Future Directions. Due to the limited availability of large multi-omics datasets and com-
prehensive collections of clinical phenotypes, our study is restricted by the relatively small sample size of 510 
individuals and, more importantly, we were not able to get access to comparable data from an independent cohort 
to replicate our results. Also, all of our participants are female. As a consequence, our model and the conclusions 
drawn from it might be only partly transferable to the entire population. However, more and larger multi-omics 
dataset will be available in near future, for instance from the UK Biobank or the US Precision Medicine Initiative, 
which will facilitate subsequent studies using our multi-omics integration approach. For the time being, we could 
only demonstrate the stability of our results by inferring separate models from two disjoint sets of our own dataset 
that include only one twin of each twin pair, respectively (Supplementary Fig. S5). The limited number of samples 
also made prior selection of variables indispensable. This selection can be expected to influences the topology 
and modularity of the final network model. However, in our study, doubling the number of omics variables 
by not pre-selecting metabolites from the metabolomics data did result in very similar topology and module 
assignments in the model (Supplementary Table S4). Also, upcoming larger datasets will allow to overcome this 
limitation by reducing the dimensionality of the data without relying on variable selection based on prior associa-
tion analyses. While stability selection controls the family-wise error rate (FWER) of edges in the step of network 
inference, stability selection cannot quantify the total uncertainty in the model and its downstream analyses. 
However, analyzing the sensitivity of our approach against variations in the inferred network model (e.g. through 
different threshold for the selection of edges) demonstrated the stability of our results (Supplementary Fig S4, S5 
and Table S4). Finally, our approach allows to detect mediation by variables included in the model and thereby 
enables differentiation between direct and indirect effects, it does, however, not allow to infer causality. Thus, 
based on our model, we only hypothesize about causal directions. Mendelian randomization might enable infer-
ence of causal direction using SNPs as instrumental variables. Much larger sample sizes are needed than available 
for this study, though. Ideally, potentially causal edges in our model should be further investigated in dedicated 
functional studies or randomized clinical trials to establish causality and infer causal direction.
Conclusion
This is, to our knowledge, the first study integrating data from four omics technologies and clinical phenotypes 
using an integrated statistical approach. Despite the relatively small sample size, our model confirms causal mech-
anisms of disease, which have been previously found using highly specific experiments and clinical trials, purely 
based on observational data from a generally healthy cohort. Moreover, we uncovered several new potential 
mechanisms that might contribute to disease comorbidities. We found, for instance, urate as key factor connect-
ing body composition and renal function, as well as several phenotypes of the metabolic syndrome. Moreover, by 
integrating multiple omics datasets, we find the hormone oxytocin as a central mediator that connects inflamma-
tion and obesity and, thus, supports the theory of inflammaging.
Our study highlights the importance and the feasibility of data integration across omics layers including phe-
nomics while considering multivariate dependencies. In the future this will help to focus on few, interesting asso-
ciations, which can then be specifically tested in model organisms and clinical trials. Eventually this will speed 
up drug discovery by excluding irrelevant pathways and potential drug targets early in the development and thus 
limiting the set of potential targets and reducing costs of drug discovery.
Materials and Methods
Study Population. We analyzed data from the TwinsUK cohort, a national register of 11,000 adult twins 
recruited as volunteers without selecting for any particular disease or trait. For this study we selected 510 female 
participants (62 monozygotic twin pairs, 116 dizygotic twin pairs and 154 singletons) aged between 34 and 84 
(mean 59.0 ± 9.4) with measurements for epigenomics, transcriptomics, glycomics and metabolomics available. 
The study has been approved by the local St. Thomas’ Hospital Research Ethics Committee and was carried out in 
accordance with the approved guidelines. All study participants provided written informed consent.
Data Acquisition and Processing. The phenotypic data was collected using questionnaires and anthro-
pometric measures during hospital visits. Additionally, four different high-throughput omics datasets were ana-
lyzed. With several hundred measured metabolites, thousands of RNA transcripts and particularly hundreds of 
thousands of CpG sites, network inference is not feasible. We used a knowledge-driven approach to reduce the 
number of variables from each dataset. To this end, we selected only variables which were previously reported 
to be strongly (and independently) associated with chronological age as described in the following (and listed in 
Supplementary Table S1).
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Epigenomics. DNA methylation levels were measured in adipose tissue samples using Infinium 
HumanMethylation450 BeadChip (Illumina Inc., San Diego, CA) as previously described53. Data was corrected 
for technical variation using the beta mixture quantile dilation (BMIQ) method and corrected for batch effects 
and bisulfite conversion levels using linear mixed effect models. Weidner and colleagues54 showed that only three 
aging related differentially methylated regions (aDMRs) are enough to predict the chronological age with high 
precision. Those three sites, namely cg02228185 (in ASPA), cg25809905 (in ITGA2B) and cg17861230 (PDE4C), 
were selected for further analyses.
Transcriptomics. RNA abundance was measured in abdominal fat samples using the Illumina Human HT-12 
V3 Bead chip as part of the MuTHER project as previously described55. The probe intensities were adjusted for 
batch effects using linear models prior to analysis. A previous study found 188 genes (199 probes) significantly 
associated with chronological56 age. We performed stepwise regression to select expression probes independently 
associated with age. This procedure left 24 probes from 24 different genes (see Supplementary Table S1 for full 
list) for further analysis.
Glycomics. For this study IgG glycans were measured in a high-throughput manner as described by Pucic and 
colleagues57. Briefly, IgG was first isolated from 90μ l plasma, the attached glycans were released, labelled with 
2-aminobenzamide and analyzed by UPLC. The according chromatograms were divided in 24 glycan peaks (GP), 
corresponding to 24 glycan structures. The data has been described in detail before58. Glycan peaks were global 
normalized, log transformed and corrected for batch effects using ComBat. It has been shown that a linear com-
bination of only three IgG glycan structures - GP6, GP14 and GP15 - explains 58% percent of the variance in age8 
and furthermore correlates with several aging associated phenotypes. These three structures were selected for our 
network analysis.
Metabolomics. An untargeted LC/MS and GC/MS platform was used to measure metabolite spectra from 
plasma and serum samples, respectively. Metabolites were subsequently identified by Metabolon Inc., Durham, 
USA, using their proprietary database9. Metabolite levels were scaled by the run-day median, imputed using the 
run-day minimum, inverse normalized and corrected for batch effects using linear mixed models with the batch 
as random intercept. About the half of all known circulating blood metabolites were reported to be associated 
with chronological age in several large population studies9. We selected 22 of these metabolites, which were 
shown to be independently associated with age and together explain 59% of the variance of chronological age9.
Clinical Phenotypes. A total of 92 phenotypes was combined with the previously described omics data 
(listed in Supplementary Table S2). Besides the chronological age, we included 13 body composition variables, 
measured by dual-energy X-ray absorptiometry (DXA), as previously described59. In addition to DXA meas-
urements we included common body composition measures, such as height, weight, waist and hip circumfer-
ences and body mass index (BMI). Lung function was assessed by measuring the forced expiratory volume in 
one second (FEV1) and the forced vital capacity (FVC) using standard spirometry60. Biochemical measures of 
gamma-glutamyltranserase (GGT) and alanine aminotransaminase (ALAT) were used to determine liver func-
tion. We furthermore used the CKD-EPI equation61 to estimate the glomerular filtration rate (eGFR) from serum 
creatinine as measure of renal function. Moreover, we included data from various questionnaires, assessing dis-
ease states, such as arthritis, asthma and chronic pain. Additionally, questionnaires were used to collect lifestyle 
parameters. Amongst others, we included data about physical activity and nutrition. Food intake data was col-
lected using an established food frequency questionnaire62. Item frequencies were merged into 54 food groups 
and transformed into orthogonal patterns using principal component analysis63. We used the first five principal 
components, which correspond to five different dietary patterns (Supplementary Table S3), in our model. A com-
plete list of phenotypes is shown in Supplementary Table S2.
Data Pre-Processing. We excluded samples with more than 20% missing values and subsequently excluded var-
iables with more than 20% missing values. Remaining missing values were imputed using the mice package64. 
All continuous variables were inverse normalized and categorical variables were dichotomized. To account for 
family relatedness, we included one variable indicating a unique identifier per family during network inference 
and removed the according node from the network prior to analysis.
Data Availability. The transcriptomics and epigenomics data are available at ArrayExpress (accession num-
ber E-TABM-1140 and E-MTAB-1866, respectively). All other TwinsUK omics data are publicly available upon 
request on the departmental website (http://www.twinsuk.ac.uk/data-access/accessmanagement/).
Network Inference. The mixed graphical model was inferred using the Graphical Random Forest (GRaFo) 
method21 with the complementary pairs stability selection (CPSS) modification65. Briefly, for each variable all 
remaining variables were ranked according to their conditional dependence assessed by the random forest var-
iable importance. Consequently, two ranks were calculated for each pair of variables x and y: one based on the 
variable importance of x for the prediction of y and the other based on the importance of y for the prediction of x. 
The maximum (i.e. worse) of these two ranks was used as rank of the pair and the best ranking pairs were added 
as edges of the graphical model. This procedure was repeated for 100 random subsets of the data, each containing 
the half of all samples, and their complementary set containing the other half of the samples. The resulting 200 
graphical models were combined using CPSS65 to control the family-wise error rate (FWER). Edges which were 
contained in more than 80% of all complementary pairs were included in the final model, thereby ensuring FWER 
< 0.05. As effect estimators from random forest, and partial effects in mixed models in general, are non-linear 
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and depend on other variables in the model, there is no estimator for the sign of an edge in our model. We, thus, 
inferred the signs from regression models, regressing each variable against all others, for visualization purposes.
Network Analysis. We analyzed the graphical model as undirected, unweighted network G = (V, E), consisting 
of a set of vertices V and a set of edges E.
Several measures were calculated to assess the centrality of nodes in the network. The degree of a node v 
is defined as the number of edges that contain this node, thus assessing its direct associations. The clustering 
coefficient is the proportion of edges within the neighborhood of v that are present in the network. It measures 
the centrality of v within its local neighborhood. In contrast, the betweenness centrality considers indirect asso-
ciations of v and assesses its importance for the network integrity. It is defined as the proportion of all shortest 
paths that contain v12. Real-world networks often consist of densely connected modules, so-called clusters or 
communities that represent functional units within the network66. We used an unbiased way to identify clusters 
within our model, independently from the type of a variable. To this end, we used the algorithm of Brandes and 
colleagues67. It optimizes the modularity score that increases with the number of intra-cluster edges and decreases 
with the number of inter-cluster edges. Despite the high local clustering, many biological networks are character-
ized by short average path lengths between nodes. These networks are referred to as small world networks. This 
concept was formalized by Humphries22, who introduced the small word index for networks, that assesses the 
small-world-ness of a network by comparing its clustering coefficient and average shortest path lengths with an 
Erdös-Rényi random graph.
Network Stability. To test the robustness of our model we investigated the dependence of the network topology 
on the inference process.
Firstly, we assessed robustness of node centrality as well as module assignments when varying the cutoff for 
edge inclusion. To this end, we defined different models by including edges that are contained in 20%, 40%, 60%, 
80% and 100% of the subsamples, respectively, where 80% corresponds to the original model. Additionally, we 
analyzed a weighted network68 including all edges that were observed in at least one subsample. As a measure of 
stability of node centrality, we determined the correlation of node degrees and clustering coefficients between the 
original model and the model in the networks for different edge cutoffs (Supplementary Fig. S4). To assess the 
stability of module assignments, we calculated the adjusted RAND index69 as a measure of similarity between the 
seven network modules of the original age-mgm with modules identified from the networks that were inferred 
based on different edge cutoffs. The RAND index assesses the similarity of module assignments by counting the 
agreements between two different module assignments and adjusting it for the number of agreements that are 
expected by chance. An adjusted RAND index of 1.0 indicates identity between the module assignments of two 
networks while values around 0.0 indicate dissimilarity of the assigned modules. In addition, we compared the 
adjusted RAND indices of the networks for the different edge cutoffs with the background distribution of 1000 
randomly sampled module assignments (Supplementary Fig. S4C).
Secondly, we investigated the stability of the network and, in particular, the module assignments depending 
on the pre-selection of omics variables prior to the model inference. To assess the influence of this selection step 
on our results we inferred a second model from the same dataset but this time including all metabolomics var-
iables with known chemical identity, thus, completely dispensing variable selection for the metabolomics data. 
The resulting graph consist of 341 nodes (145 of them from the original model and 196 newly added) connected 
by 1152 edges. 707 of these edges are amongst the new metabolites, 174 connect one new metabolite with one 
original variable and 271 edges are amongst original variables, of which 253 are also in the original model. The 
63 edges that are missing in the large network compared to the original model are, on average, contained in 58% 
of the subsamples of the large network, suggesting that they were excluded due to the limited power. We find the 
added metabolites predominantly peripheral to the age-mgm, with 160 of the 174 edges connecting new metab-
olites with original variables being amongst metabolites and the remaining 14 with either blood lipid measures 
or renal function. A graphml file of the large network can be found in the Supplementary Dataset S1. To compare 
module assignments for the large network with the assignments for the original age-mgm, we restricted the large 
network to the nodes of the age-mgm. Edges in this network represent conditional dependence, given all other 
variable in the age-mgm and additionally given the 196 added metabolites. We assigned modules using the spin-
glass algorithm implemented in the igraph package (as calculating the optimal modularity is computationally 
expensive for large networks). Module assignments are compared using adjusted RAND index and comparison 
of detailed module membership (Supplementary Table S4).
The stability of the model depending on the underlying sample sets was assessed by comparing our initial 
model with models inferred from two disjoint datasets containing either the first or the second twin of each fam-
ily, respectively. Singletons were distributed randomly across both datasets. The resulting models are provided in 
graphml format in Supplementary Dataset S1.
All data was analyzed using R (version 3.1.2) along with the randomForest (version 4.6), igraph70 (version 1.0.1) 
and ggplot271 packages. The final network model is available as graphml file in the Supplementary Dataset S1.
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